Drug Approval Package

 Forteo [teriparatide (rDNA origin)] Injection
Company:  Eli Lilly and Company
Application No.:  021318
Approval Date: 11/26/2002

• Approval Letter(s) (PDF)

• Printed Labeling (PDF)

• Medical Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)  
  Part 3 (PDF)  
  Part 4 (PDF)  
  Part 5 (PDF)  
  Part 6 (PDF)  

• Chemistry Review(s) (PDF)

• Pharmacology Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)  
  Part 3 (PDF)  
  Part 4 (PDF)  

• Statistical Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)

• Microbiology Review(s) (PDF)  

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)

• Administrative Document(s)
  Part 1 (PDF)  
  Part 2 (PDF)  
  Part 3 (PDF)  
  Part 4 (PDF)  
  Part 5 (PDF)   

Date created: March 242004

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.